Laden...
Having trouble viewing this email? View it as a Web page. You are receiving this message because you are subscribed to News Releases for National Institutes of Health (NIH). Antiviral drug not beneficial for reducing mother-to-child transmission of hepatitis B when added to existing preventatives 03/07/2018 05:00 PM ESTNIH-funded study observes no significant reduction of infection rates at age 6 months. Update Your E-mail Address | Add Subscriptions | Unsubscribe If you have questions or problems with the subscription service, please contact subscriberhelp.govdelivery.com. For all other inquiries about NIH programs and activities, please contact NIHinfo@od.nih.gov. Before writing, please view ourFrequently Asked Questions page, our Health Information page, or Search our website. This service is provided to you by the National Institutes of Health. |
Laden...
Laden...
© 2024